The DOI matches its Crossref record; 341 of the 341 references it cites were found in a registry or an index.
Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis
Open accessAbstract
There is highly credible evidence that melatonin mitigates cancer at the initiation, progression and metastasis phases. In many cases, the molecular mechanisms underpinning these inhibitory actions have been proposed. What is rather perplexing, however, is the large number of processes by which melatonin reportedly restrains cancer development and growth. These diverse actions suggest that what is being observed are merely epiphenomena of an underlying more fundamental action of melatonin that remains to be disclosed. Some of the arresting actions of melatonin on cancer are clearly membrane receptor-mediated while others are membrane receptor-independent and involve direct intracellular actions of this ubiquitously-distributed molecule. While the emphasis of melatonin/cancer research has been on the role of the indoleamine in restraining breast cancer, this is changing quickly with many cancer types having been shown to be susceptible to inhibition by melatonin. There are several facets of this research which could have immediate applications at the clinical level. Many studies have shown that melatonin’s co-administration improves the sensitivity of cancers to inhibition by conventional drugs. Even more important are the findings that melatonin renders cancers previously totally resistant to treatment sensitive to these same therapies. Melatonin also inhibits molecular processes associated with metastasis by limiting the entrance of cancer cells into the vascular system and preventing them from establishing secondary growths at distant sites. This is of particular importance since cancer metastasis often significantly contributes to death of the patient. Another area that deserves additional consideration is related to the capacity of melatonin in reducing the toxic consequences of anti-cancer drugs while increasing their efficacy. Although this information has been available for more than a decade, it has not been adequately exploited at the clinical level. Even if the only beneficial actions of melatonin in cancer patients are its ability to attenuate acute and long-term drug toxicity, melatonin should be used to improve the physical wellbeing of the patients. The experimental findings, however, suggest that the advantages of using melatonin as a co-treatment with conventional cancer therapies would far exceed improvements in the wellbeing of the patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Chuffa, L. G. D. A., Fioruci-Fontanelli, B. A., Mendes, L. D. O., Seiva, F. R. F., Martinez, M., Fávaro, W. J., Domeniconi, R. F., Pinheiro, P. F. F., dos Santos, L. D., & Martinez, F. E. (2015) · BMC Cancer · doi:10.1186/s12885-015-1032-4 · Cited by 103
RetractedFan, C., Pan, Y., Yang, Y., Di, S., Jiang, S., Ma, Z., Li, T. X., Zhang, Z., Li, W., Li, X., et al. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12261 · Cited by 59
Self-citationRetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Hynes (2002) · doi:10.1016/s0092-8674(02)00971-6 · Cited by 8,606
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Remodelling the extracellular matrix in development and disease
Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367 · cited 2×
“ECM provides not only essential physical scaffolding for adhesion molecules to attach but also serves as a ligand reservoir by sequestering various growth factors such as basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) [336].”
BackgroundATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
Basic and Therapeutic Aspects of Angiogenesis
Potente, M., Gerhardt, H., & Carmeliet, P. (2011) · Cell · doi:10.1016/j.cell.2011.08.039 · Cited by 2,771
PI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,443
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Regulation of antioxidant enzymes: a significant role for melatonin
Rodriguez, C., Mayo, J. C., Sainz, R. M., Antolín, I., Herrera, F., Martín, V., & Reiter, R. J. (2004) · Journal of Pineal Research · doi:10.1046/j.1600-079x.2003.00092.x · Cited by 1,987
Self-citationThe DNA Damage Response: Ten Years After
Harper, J. W., & Elledge, S. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.015 · Cited by 1,705
Melatonin as an antioxidant: under promises but over delivers
Reiter, R. J., Mayo, J. C., Tan, D., Sainz, R. M., Alatorre‐Jimenez, M., & Qin, L. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12360 · Cited by 1,703
Self-citationMelatonin : a potent, endogenous hydroxyl radical scavenger
Tan, D. (1993) · Endocrine Journal · Cited by 1,659
Self-citationThe DNA damage response and cancer therapy
Lord, C. J., & Ashworth, A. (2012) · Nature · doi:10.1038/nature10760 · Cited by 1,649
Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways
Onder, T. T., Gupta, P. B., Mani, S. A., Yang, J., Lander, E. S., & Weinberg, R. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2938 · Cited by 1,522
Targeting the DNA Damage Response in Cancer
O’Connor, M. J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.040 · Cited by 1,518
Nishida, N., Yano, H., Nishida, T., Kamura, T., & Kojiro, M. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.213 · Cited by 1,434
Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease
Acloque, H., Adams, M. S., Fishwick, K., Bronner-Fraser, M., & Nieto, M. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38019 · Cited by 1,370
Oxidative stress and cancer: Have we moved forward?
Halliwell, B. (2007) · Biochemical Journal · doi:10.1042/bj20061131 · Cited by 1,302
The metastatic niche: adapting the foreign soil
Psaila, B., & Lyden, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2621 · Cited by 1,300
Hudson, C. C., Liu, M., Chiang, G. G., Otterness, D. M., Loomis, D. C., Kaper, F., Giaccia, A. J., & Abraham, R. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7004-7014.2002 · Cited by 1,186
Actions of melatonin in the reduction of oxidative stress: A review
Reiter, R. J., Tan, D.-X., Osuna, C., & Gitto, E. (2000) · Journal of Biomedical Science · doi:10.1007/bf02253360 · Cited by 1,177
Self-citationDubbels, R., Reiter, R. J., Klenke, E., Goebel, A., Schnakenberg, E., Ehlers, C., Schiwara, H. W., & Schloot, W. (1995) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1995.tb00136.x · Cited by 1,103
Self-citationExtrapineal melatonin: sources, regulation, and potential functions
Acuña-Castroviejo, D., Escames, G., Venegas, C., Díaz-Casado, M. E., Lima-Cabello, E., López, L. C., Rosales-Corral, S., Tan, D.-X., & Reiter, R. J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1579-2 · Cited by 1,076
Self-citationHot L1s account for the bulk of retrotransposition in the human population
Brouha, B., Schustak, J., Badge, R. M., Lutz-Prigge, S., Farley, A. H., Moran, J. V., & Kazazian, H. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831042100 · Cited by 1,073
Complex iii releases superoxide to both sides of the inner mitochondrial membrane
Muller, F. L., Liu, Y., & Van Remmen, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407715200 · Cited by 1,036
Cross, M. J., & Claesson-Welsh, L. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01676-x · Cited by 989
Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals
Prasad, S., Gupta, S. C., & Tyagi, A. K. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.03.042 · Cited by 978
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
Nieto, M. A. (2013) · Science · doi:10.1126/science.1234850 · Cited by 967
The basic physiology and pathophysiology of melatonin
Claustrat, B., Brun, J., & Chazot, G. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.08.001 · Cited by 950
Melatonin: an ancient molecule that makes oxygen metabolically tolerable
Manchester, L. C., Coto‐Montes, A., Boga, J. A., Andersen, L. P. H., Zhou, Z., Galano, A., Vriend, J., Tan, D., & Reiter, R. J. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12267 · Cited by 945
Self-citationReactive oxygen species and cancer paradox: To promote or to suppress?
Galadari, S., Rahman, A., Pallichankandy, S., & Thayyullathil, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.004 · Cited by 893
Molecular mechanisms of ROS production and oxidative stress in diabetes
Newsholme, P., Cruzat, V. F., Keane, K. N., Carlessi, R., & de Bittencourt, P. I. H. (2016) · Biochemical Journal · doi:10.1042/bcj20160503c · Cited by 878
Hattori, A., Migitaka, H., Iigo, M., Itoh, M., Yamamoto, K., Ohtani‐Kaneko, R., Hara, M., Suzuki, T., & Reiter, R. J. (1995) · PubMed · Cited by 827
Self-citationMelatonin: a well‐documented antioxidant with conditional pro‐oxidant actions
Zhang, H., & Zhang, Y. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12162 · Cited by 813
Li, X., Fang, P., Mai, J., Choi, E. T., Wang, H., & Yang, X.-F. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-19 · Cited by 812
On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK
Galano, A., Tan, D. X., & Reiter, R. J. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12010 · Cited by 795
Self-citationp53: oncogene or anti-oncogene?
Lane, D. P., & Benchimol, S. (1990) · Genes & Development · doi:10.1101/gad.4.1.1 · Cited by 795
IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer
Gyrd-Hansen, M., & Meier, P. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2889 · Cited by 790
Heerboth, S., Housman, G., Leary, M., Longacre, M., Byler, S., Lapinska, K., Willbanks, A., & Sarkar, S. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0048-3 · Cited by 739
The chemistry of melatonin's interaction with reactive species
Allegra, M., Reiter, R. J., Tan, D. ‐., Gentile, C., Tesoriere, L., & Livrea, M. A. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.02112.x · Cited by 718
Self-citationHardeland, R. (2005) · Endocrine · doi:10.1385/endo:27:2:119 · Cited by 671
A Review of the Multiple Actions of Melatonin on the Immune System
Carrillo-Vico, A., Guerrero, J. M., Lardone, P. J., & Reiter, R. J. (2005) · Endocrine · doi:10.1385/endo:27:2:189 · Cited by 666
Self-citationMelatonin: The chemical expression of darkness
Reiter, R. J. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90087-9 · Cited by 632
Self-citationKwon, J., Lee, S.-R., Yang, K.-S., Ahn, Y., Kim, Y. J., Stadtman, E. R., & Rhee, S. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407396101 · Cited by 631 · cited 2×
“kinas B) phosphatases including phosphatase and tensin homolog (PTEN) as well as protein tyrosine phosphatase 1B (PTP1B) [162,163]; these changes may expedite pro-proliferative P13K/AKT signaling [164].”
BackgroundDubocovich, M. L., Delagrange, P., Krause, D. N., Sugden, D., Cardinali, D. P., & Olcese, J. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002832 · Cited by 621
Melatonin: Exceeding Expectations
Reiter, R. J., Tan, D. X., & Galano, A. (2014) · Physiology · doi:10.1152/physiol.00011.2014 · Cited by 605
Self-citationChan, S. R. W. L., & Blackburn, E. H. (2004) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1370 · Cited by 595
The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy
Goldstein, M., & Kastan, M. B. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-081313-121208 · Cited by 590
Therapeutic opportunities within the DNA damage response
Pearl, L. H., Schierz, A. C., Ward, S. E., Al-Lazikani, B., & Pearl, F. M. G. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3891 · Cited by 587
Mechanisms, mechanics and function of epithelial–mesenchymal transitions in early development
Shook, D., & Keller, R. (2003) · Mechanisms of Development · doi:10.1016/j.mod.2003.06.005 · Cited by 582
Heavy ion carcinogenesis and human space exploration
Durante, M., & Cucinotta, F. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2391 · Cited by 578
Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations
Venegas, C., García, J. A., Escames, G., Ortiz, F., López, A., Doerrier, C., García‐Corzo, L., López, L. C., Reiter, R. J., & Acuña‐Castroviejo, D. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00931.x · Cited by 577
Self-citationThe detrimental effects of lead on human and animal health
Assi, M. A., Hezmee, M. N. M., Haron, A. W., Sabri, M. Y., & Rajion, M. A. (2016) · Veterinary World · doi:10.14202/vetworld.2016.660-671 · Cited by 566
Necroptosis: A Specialized Pathway of Programmed Necrosis
Galluzzi, L., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2008.12.004 · Cited by 561 · cited 2×
“, type III programmed cell death [171], the recently-described ferroptosis which depends on intracellular iron concentrations but is non-apoptotic [172] and chemosensitization of tumor cells to conventional chemotherapies [173,174].”
BackgroundMelatonin stimulates brain glutathione peroxidase activity
Barlow-Walden, L. R., Reiter, R. J., Abe, M., Pablos, M., Menendez-Pelaez, A., Chen, L.-D., & Poeggeler, B. (1995) · Neurochemistry International · doi:10.1016/0197-0186(94)00154-m · Cited by 549
Self-citationSingle-Neuron Sequencing Analysis of L1 Retrotransposition and Somatic Mutation in the Human Brain
Evrony, G. D., Cai, X., Lee, E., Hills, L. B., Elhosary, P. C., Lehmann, H. S., Parker, J. J., Atabay, K. D., Gilmore, E. C., Poduri, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.09.035 · Cited by 548 · cited 1×
“As observed in neurons, Evrony and colleagues [126] have shown that the expression of a small percentage of the fixed active L1s, and perhaps some polymorphic loci, cause 0.”
BackgroundMadesh, M., & Hajnóczky, G. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105057 · Cited by 538
Androgen receptor signaling in prostate cancer development and progression
Tindall, D., & Lonergan, P. (2011) · Journal of Carcinogenesis · doi:10.4103/1477-3163.83937 · Cited by 535
Li, L., Li, C., Wang, S., Wang, Z., Jiang, J., Wang, W., Li, X., Chen, J., Liu, K., Li, C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1625 · Cited by 532
Melatonin, hydroxyl radical‐mediated oxidative damage, and aging: A hypothesis
Poeggeler, B., Reiter, R. J., Tan, D., Chen, L., & Manchester, L. C. (1993) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1993.tb00498.x · Cited by 501
Self-citationLoss of tight junction barrier function and its role in cancer metastasis
Martin, T. A., & Jiang, W. G. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.11.005 · Cited by 492
VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
Saharinen, P., Eklund, L., Pulkki, K., Bono, P., & Alitalo, K. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.015 · Cited by 478
Wnt Signaling Mediates Self-Organization and Axis Formation in Embryoid Bodies
ten Berge, D., Koole, W., Fuerer, C., Fish, M., Eroglu, E., & Nusse, R. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.09.013 · Cited by 477
Hardeland, R., Tan, D., & Reiter, R. J. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00701.x · Cited by 472
Self-citationThe Safety of Melatonin in Humans
Andersen, L. P. H., Gögenur, I., Rosenberg, J., & Reiter, R. J. (2016) · Clinical Drug Investigation · doi:10.1007/s40261-015-0368-5 · Cited by 468
Self-citationMolecular pharmacology regulation and function of mammalian melatonin receptors
Dubocovich, M. L. (2003) · Frontiers in Bioscience · doi:10.2741/1089 · Cited by 451
Hardeland, R., Madrid, J. A., Tan, D., & Reiter, R. J. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00934.x · Cited by 448
Self-citationNew Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling Network
Dai, Y., & Grant, S. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1029 · Cited by 439
Blask, D. E., Brainard, G. C., Dauchy, R. T., Hanifin, J. P., Davidson, L. K., Krause, J. A., Sauer, L. A., Rivera-Bermudez, M. A., Dubocovich, M. L., Jasser, S. A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1945 · Cited by 432
??-Linolenic acid metabolism in men and women: nutritional and biological implications
Burdge, G. (2004) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200403000-00006 · Cited by 426
Melatonin: reducing the toxicity and increasing the efficacy of drugs
Reiter, R. J., Tan, D.-X., Sainz, R. M., Mayo, J. C., & Lopez-Burillo, S. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702760345374 · Cited by 417
Self-citation2011: the immune hallmarks of cancer
Cavallo, F., De Giovanni, C., Nanni, P., Forni, G., & Lollini, P.-L. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-010-0968-0 · Cited by 415
Mehta, V. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.03.047 · Cited by 410
Melatonin: A Mitochondrial Targeting Molecule Involving Mitochondrial Protection and Dynamics
Tan, D.-X., Manchester, L., Qin, L., & Reiter, R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122124 · Cited by 402
Self-citationUnderstanding the biology of angiogenesis: Review of the most important molecular mechanisms
Otrock, Z. K., Mahfouz, R. A. R., Makarem, J. A., & Shamseddine, A. I. (2007) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2007.04.001 · Cited by 386
Tafani, M., Sansone, L., Limana, F., Arcangeli, T., De Santis, E., Polese, M., Fini, M., & Russo, M. A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3907147 · Cited by 373
Melatonin: From Basic Research to Cancer Treatment Clinics
Vijayalaxmi, Thomas, C. R., Reiter, R. J., & Herman, T. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.004 · Cited by 361
Self-citationStevens, R. G., Blask, D. E., Brainard, G. C., Hansen, J., Lockley, S. W., Provencio, I., Rea, M. S., & Reinlib, L. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10200 · Cited by 358
The E-cadherin–catenin complex in tumour metastasis
Beavon, I. R. G. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00158-1 · Cited by 353
Melatonin and its analogs in insomnia and depression
Cardinali, D. P., Srinivasan, V., Brzezinski, A., & Brown, G. M. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00962.x · Cited by 353
POEGGELER, B., SAARELA, S., REITER, R. J., TAN, D., CHEN, L., MANCHESTER, L. C., & BARLOW‐WALDEN, L. R. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21831.x · Cited by 351
Self-citationMenendez‐Pelaez, A., & Reiter, R. J. (1993) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1993.tb00511.x · Cited by 350
Self-citationApoptosis signaling pathways in osteoarthritis and possible protective role of melatonin
Hosseinzadeh, A., Kamrava, S. K., Joghataei, M. T., Darabi, R., Shakeri‐Zadeh, A., Shahriari, M., Reiter, R. J., Ghaznavi, H., & Mehrzadi, S. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12362 · Cited by 344
Self-citationPhytomelatonin: Assisting Plants to Survive and Thrive
Reiter, R., Tan, D.-X., Zhou, Z., Cruz, M., Fuentes-Broto, L., & Galano, A. (2015) · Molecules · doi:10.3390/molecules20047396 · Cited by 335
Self-citationMelatonin: an inhibitor of breast cancer
Hill, S. M., Belancio, V. P., Dauchy, R. T., Xiang, S., Brimer, S., Mao, L., Hauch, A., Lundberg, P. W., Summers, W., Yuan, L., et al. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-15-0030 · Cited by 317
Lowes, D. A., Webster, N. R., Murphy, M. P., & Galley, H. F. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aes577 · Cited by 314
Karbownik, M., & Reiter, R. J. (2000) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1111/j.1525-1373.2000.22502.x · Cited by 313
Self-citationEmerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis
Cao, Y. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1693 · Cited by 307
Melatonin and cell death: differential actions on apoptosis in normal and cancer cells
Sainz, R. M., Mayo, J. C., Rodriguez, C., Tan, D. X., Lopez-Burillo, S., & Reiter, R. J. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-2319-1 · Cited by 305
Self-citationMelatonin: Lowering the High Price of Free Radicals
Reiter, R. J. (2000) · Physiology · doi:10.1152/physiologyonline.2000.15.5.246 · Cited by 305
Self-citationMelatonin as a radioprotective agent: a review
Vijayalaxmi, Reiter, R. J., Tan, D.-X., Herman, T. S., & Thomas, C. R. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.02.006 · Cited by 303
Self-citationLocal tumour hyperthermia as immunotherapy for metastatic cancer
Toraya-Brown, S., & Fiering, S. (2014) · International Journal of Hyperthermia · doi:10.3109/02656736.2014.968640 · Cited by 302
Clinical Uses of Melatonin: Evaluation of Human Trials
Sanchez-Barcelo, E. J., Mediavilla, M. D., Tan, D. X., & Reiter, R. J. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791233689 · Cited by 301 · cited 1×
“Yet, surprisingly, its use for this purpose at the clinical level has been remarkably sparse [158,159].”
BackgroundSelf-citationTamarkin, L., Cohen, M., Roselle, D., Reichert, C. M., Lippman, M. E., & Chabner, B. A. (1981) · PubMed · Cited by 296
Tang, H. L., Tang, H. M., Mak, K. H., Hu, S., Wang, S. S., Wong, K. M., Wong, C. S. T., Wu, H. Y., Law, H. T., Liu, K., et al. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-11-0926 · Cited by 293
PCNA on the crossroad of cancer
Stoimenov, I., & Helleday, T. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370605 · Cited by 289
The pineal gland and melatonin in relation to aging: A summary of the theories and of the data
Reiter, R. J. (1995) · Experimental Gerontology · doi:10.1016/0531-5565(94)00045-5 · Cited by 284
Self-citationDual Signaling of Human Mel1a Melatonin Receptors via Gi2, Gi3, and Gq/11 Proteins
Brydon, L. (1999) · Molecular Endocrinology · doi:10.1210/me.13.12.2025 · Cited by 281
Pozo, D., Reiter, R. J., Calvo, J. R., & Guerrero, J. M. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970601)65:3<430::aid-jcb12>3.0.co;2-j · Cited by 280
Self-citationCancer metastasis: Mechanisms of inhibition by melatonin
Su, S., Hsieh, M., Yang, W., Chung, W., Reiter, R. J., & Yang, S. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12370 · Cited by 280
Self-citationHiscox, S., Morgan, L., Green, T. P., Barrow, D., Gee, J., & Nicholson, R. I. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9120-9 · Cited by 274
Radiation-induced clustered DNA lesions: Repair and mutagenesis
Sage, E., & Shikazono, N. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.008 · Cited by 274
Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough
Cavallaro, U., & Christofori, G. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00038-5 · Cited by 269
Jahnke, G. (1999) · Toxicological Sciences · doi:10.1093/toxsci/50.2.271 · Cited by 266
Melatonin feedback on clock genes: a theory involving the proteasome
Vriend, J., & Reiter, R. J. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12189 · Cited by 264
Self-citationMelatonin as antioxidant, geroprotector and anticarcinogen
Anisimov, V. N., Popovich, I. G., Zabezhinski, M. A., Anisimov, S. V., Vesnushkin, G. M., & Vinogradova, I. A. (2006) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2006.03.012 · Cited by 264
Current and emerging concepts in tumour metastasis
Coghlin, C., & Murray, G. I. (2010) · The Journal of Pathology · doi:10.1002/path.2727 · Cited by 257
García-Becerra, R., Santos, N., Díaz, L., & Camacho, J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms14010108 · Cited by 253
Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
Cos, S., Fernández, R., Güezmes, A., & Sánchez‐Barceló, E. J. (1998) · PubMed · Cited by 246
Permethrin-induced oxidative stress and toxicity and metabolism. A review
Wang, X., Martínez, M.-A., Dai, M., Chen, D., Ares, I., Romero, A., Castellano, V., Martínez, M., Rodríguez, J. L., Martínez-Larrañaga, M.-R., et al. (2016) · Environmental Research · doi:10.1016/j.envres.2016.05.003 · Cited by 246
Recent Concepts of Ovarian Carcinogenesis: Type I and Type II
Koshiyama, M., Matsumura, N., & Konishi, I. (2014) · BioMed Research International · doi:10.1155/2014/934261 · Cited by 242
Putting Cancer to Sleep at Night: The Neuroendocrine/Circadian Melatonin Signal
Blask, D. E., Dauchy, R. T., & Sauer, L. A. (2005) · Endocrine · doi:10.1385/endo:27:2:179 · Cited by 238
Somatic expression of LINE-1 elements in human tissues
Belancio, V. P., Roy-Engel, A. M., Pochampally, R. R., & Deininger, P. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq132 · Cited by 238
Light at Night, Chronodisruption, Melatonin Suppression, and Cancer Risk: A Review
Reiter, R. J., Tan, D.-X., Korkmaz, A., Erren, T. C., Piekarski, C., Tamura, H., & Manchester, L. C. (2007) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v13.i4.30 · Cited by 236
Self-citationBasic Mechanisms Involved in the Anti-Cancer Effects of Melatonin
D. Mediavilla, M., J. Sanchez-Barcelo, E., X. Tan, D., Manchester, L., & J. Reiter, R. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710794183015 · Cited by 234
Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer
Jung‐Hynes, B., Reiter, R. J., & Ahmad, N. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00729.x · Cited by 233
Self-citationMelatonin–estrogen interactions in breast cancer
Sánchez‐Barceló, E. J., Cos, S., Mediavilla, D., Martínez‐Campa, C., González, A., & Alonso‐González, C. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00207.x · Cited by 228
Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis
Cao, R., Ji, H., Feng, N., Zhang, Y., Yang, X., Andersson, P., Sun, Y., Tritsaris, K., Hansen, A. J., Dissing, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208324109 · Cited by 225
Mechanisms of cancer inhibition by melatonin
Reiter, R. J. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00165.x · Cited by 223
Self-citationAnti-angiogenic activity of melatonin in advanced cancer patients.
Lissoni, P., Rovelli, F., Malugani, F., Bucovec, R., Conti, A., & Maestroni, G. J. M. (2001) · PubMed · Cited by 215
Lissoni, P., Chilelli, M., Villa, S., Cerizza, L., & Tancini, G. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00032.x · Cited by 211
Pablos, M. I., Reiter, R. J., Ortiz, G. G., Guerrero, J. M., Agapito, M. T., Chuang, J.-I., & Sewerynek, E. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00043-0 · Cited by 210
Self-citationTherapeutic Actions of Melatonin in Cancer: Possible Mechanisms
Srinivasan, V., Spence, D. W., Pandi-Perumal, S. R., Trakht, I., & Cardinali, D. P. (2008) · Integrative Cancer Therapies · doi:10.1177/1534735408322846 · Cited by 208
Galano, A., Medina, M. E., Tan, D. X., & Reiter, R. J. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12196 · Cited by 199
Self-citationPablos, M. I., Agapito, M. T., Gutierrez, R., Recio, J. M., Reiter, R. J., Barlow‐Walden, L., Acuña‐Castroviejo, D., & Menendez‐Pelaez, A. (1995) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1995.tb00178.x · Cited by 194
Self-citationThe role of the cellular antioxidant defense in oxidant carcinogenesis.
Cerutti, P., Ghosh, R., Oya, Y., & Amstad, P. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.94102s10123 · Cited by 193
Maria, S., & Witt‐Enderby, P. A. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12116 · Cited by 189
Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review
Bizzarri, M., Proietti, S., Cucina, A., & Reiter, R. J. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.834890 · Cited by 189
Self-citationReiter, R. J., Tan, D. X., Burkhardt, S., & Manchester, L. C. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2001.tb07018.x · Cited by 189
Self-citationAll y’all need to know ‘bout retroelements in cancer
Belancio, V. P., Roy-Engel, A. M., & Deininger, P. L. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.06.001 · Cited by 188
Blask, D. E., Hill, S. M., Dauchy, R. T., Xiang, S., Yuan, L., Duplessis, T., Mao, L., Dauchy, E., & Sauer, L. A. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00888.x · Cited by 187
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
Tian, H., Gao, Z., Li, H., Zhang, B., Wang, G., Zhang, Q., Pei, D., & Zheng, J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.12.038 · Cited by 186
Neurotoxins: Free radical mechanisms and melatonin protection
J. Reiter, R., C. Manchester, L., & Tan, D.-X. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246236 · Cited by 179
Self-citationChan, A. S. L., Lai, F. P. L., Lo, R. K. H., Voyno-Yasenetskaya, T., Stanbridge, E. J., & Wong, Y. H. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00240-6 · Cited by 176
Melatonin and sirtuins: A “not-so unexpected” relationship
Mayo, J. C., Sainz, R. M., González Menéndez, P., Cepas, V., Tan, D., & Reiter, R. J. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12391 · Cited by 175
Self-citationKarbownik‐Lewińska, M., Lewinski, A., & Reiter, R. J. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00059-0 · Cited by 173
Self-citationMelatonin reduces lipid peroxidation and membrane viscosity
Reiter, R. J., Tan, D., & Galano, A. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00377 · Cited by 172
Self-citationThe Tight Junction Protein, Occludin, Regulates the Directional Migration of Epithelial Cells
Du, D., Xu, F., Yu, L., Zhang, C., Lu, X., Yuan, H., Huang, Q., Zhang, F., Bao, H., Jia, L., et al. (2010) · Developmental Cell · doi:10.1016/j.devcel.2009.12.008 · Cited by 169
Melatonin, an Endogenous-specific Inhibitor of Estrogen Receptor α via Calmodulin
del Río, B., Garcia-Pedrero, J. M., Martínez‐Campa, C., Zuazua, P., Lazo, P. S., & Ramos, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403140200 · Cited by 169
Melatonin attenuates traumatic brain injury‐induced inflammation: a possible role for mitophagy
Lin, C., Chao, H., Li, Z., Xu, X., Liu, Y., Hou, L., Liu, N., & Ji, J. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12337 · Cited by 168
Melatonin protects human blood lymphocytes from radiation-induced chromosome damage
Vijayalaxmi, Reiter, R. J., & Meltz, M. L. (1995) · Mutation Research Letters · doi:10.1016/0165-7992(95)90065-9 · Cited by 164
Self-citationJou, M., Peng, T., Hsu, L., Jou, S., Reiter, R. J., Yang, C., Chiao, C., Lin, Y., & Chen, C. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00721.x · Cited by 163
Self-citationAmstrup, A. K., Sikjaer, T., Heickendorff, L., Mosekilde, L., & Rejnmark, L. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12252 · Cited by 162
Melatonin potentiates chemotherapy‐induced cytotoxicity and apoptosis in rat pancreatic tumor cells
Uguz, A. C., Cig, B., Espino, J., Bejarano, I., Naziroglu, M., Rodríguez, A. B., & Pariente, J. A. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.00974.x · Cited by 162
Dauchy, R. T., Xiang, S., Mao, L., Brimer, S., Wren, M. A., Yuan, L., Anbalagan, M., Hauch, A., Frasch, T., Rowan, B. G., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3156 · Cited by 161
Melatonin inhibits telomerase activity in the MCF‐7 tumor cell line both in vivo and in vitro
Leon-Blanco, M. M., Guerrero, J. M., Reiter, R. J., Calvo, J. R., & Pozo, D. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00077.x · Cited by 161
Self-citationMelatonin suppresses cisplatin-induced nephrotoxicity via activation of Nrf-2/HO-1 pathway
Kilic, U., Kilic, E., Tuzcu, Z., Tuzcu, M., Ozercan, I. H., Yilmaz, O., Sahin, F., & Sahin, K. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-7 · Cited by 160
Mao, L., Yuan, L., Slakey, L. M., Jones, F. E., Burow, M. E., & Hill, S. M. (2010) · Breast Cancer Research · doi:10.1186/bcr2794 · Cited by 160
Sainz, R. M., Mayo, J. C., Tan, D.-X., León, J., Manchester, L., & Reiter, R. J. (2005) · The Prostate · doi:10.1002/pros.20155 · Cited by 159
Self-citationThe neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappa B.
Mohan, N., Sadeghi, K., Reiter, R. J., & Meltz, M. L. (1995) · PubMed · Cited by 159
Self-citationCos, S., Blask, D. E., Lemus-Wilson, A. M., & Hill, A. B. (1991) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1991.tb00007.x · Cited by 155
Radioprotective Agents: Strategies and Translational Advances
Kamran, M. Z., Ranjan, A., Kaur, N., Sur, S., & Tandon, V. (2016) · Medicinal Research Reviews · doi:10.1002/med.21386 · Cited by 155
Reactive oxygen species regulation of autophagy in cancer: Implications for cancer treatment
Li, L., Ishdorj, G., & Gibson, S. B. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.07.011 · Cited by 154
Ortiz, F., Acuña-Castroviejo, D., Doerrier, C., Dayoub, J. C., López, L. C., Venegas, C., García, J. A. G., López, A., Volt, H., Luna‐Sánchez, M., et al. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12191 · Cited by 153
Lin, Y., Lee, L.-M., Lee, W.-J., Chu, C., Tan, P., Yang, Y., Chen, W., Yang, S., Hsiao, M., & Chien, M. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12308 · Cited by 152
Self-citationMelatonin uptake through glucose transporters: a new target for melatonin inhibition of cancer
Hevia, D., González‐Menéndez, P., Quirós-González, I., Miar, A., Rodríguez‐García, A., Tan, D. X., Reiter, R. J., Mayo, J. C., & Sainz, R. M. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12210 · Cited by 150
Self-citationBorin, T. F., Arbab, A. S., Gelaleti, G. B., Ferreira, L. C., Moschetta, M. G., Jardim‐Perassi, B. V., Iskander, A., Varma, N. R. S., Shankar, A., Coimbra, V. B., et al. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12270 · Cited by 148
Howard, S. M., Yanez, D. A., & Stark, J. M. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1004943 · Cited by 148
Augello, C., Caruso, L., Maggioni, M., Donadon, M., Montorsi, M., Santambrogio, R., Torzilli, G., Vaira, V., Pellegrini, C., Roncalli, M. G., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-125 · Cited by 147
Ramis, M., Esteban, S., Miralles, A., Tan, D.-X., & Reiter, R. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150619104143 · Cited by 146
Self-citationMincheva‐Nilsson, L., & Baranov, V. I. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.02.010 · Cited by 146
Neuroendocrine differentiation in prostate cancer
Kirby, R. S., Partin, A. W., Feneley, M. R., & Parsons, J. K. (2005) · Prostate Cancer · doi:10.1201/b14450-17 · Cited by 144
Joo, S. S., & Yoo, Y. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00682.x · Cited by 141
Epidemiology: The dominant malignancy
Bender, E. (2014) · Nature · doi:10.1038/513s2a · Cited by 141
Blask, D. E. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh090 · Cited by 141
Blask, D. E., Dauchy, R. T., Dauchy, E. M., Mao, L., Hill, S. M., Greene, M. W., Belancio, V. P., Sauer, L. A., & Davidson, L. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102776 · Cited by 141
New Approaches to Radiation Protection
Rosen, E. M., Day, R. M., & Singh, V. K. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2014.00381 · Cited by 140
Emerging role of endothelin-1 in tumor angiogenesis
Bagnato, A., & Spinella, F. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00010-3 · Cited by 139
Hong, Y., Won, J., Lee, Y., Lee, S., Park, K., Chang, K., & Hong, Y. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12119 · Cited by 138
EFFECT OF MELATONIN ON NF‐κB DNA‐BINDING ACTIVITY IN THE RAT SPLEEN
Chuang, J., Mohan, N., Meltz, M. L., & Reiter, R. J. (1996) · Cell Biology International · doi:10.1006/cbir.1996.0091 · Cited by 136
Self-citationErren, T. C., Pape, H. G., Reiter, R. J., & Piekarski, C. (2008) · Naturwissenschaften · doi:10.1007/s00114-007-0335-y · Cited by 133
Self-citationMelatonin inhibits matrix metalloproteinase‐9 activity by binding to its active site
Rudra, D. S., Pal, U., Maiti, N. C., Reiter, R. J., & Swarnakar, S. (2012) · Journal of Pineal Research · doi:10.1111/jpi.12034 · Cited by 132
Self-citationMelatonin and radioprotection from genetic damage: In vivo/in vitro studies with human volunteers
Vijayalaxmi, Reiter, R. J., Herman, T. S., & Meltz, M. L. (1996) · Mutation Research/Genetic Toxicology · doi:10.1016/s0165-1218(96)90110-x · Cited by 132
Self-citationSun, F., Lin, X., Mao, L., Ge, W., Zhang, L., Huang, Y., & Gu, J. (2002) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2002.01891.x · Cited by 130
Zapico, S. C., Rodríguez‐Blanco, J., García‐Santos, G., Martı́n, V., Sánchez‐Sánchez, A. M., Antolı́n, I., & Rodrı́guez, C. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00727.x · Cited by 127
Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells
Kiefer, T. L., Ram, P. T., Yuan, L., & Hill, S. M. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1013301408464 · Cited by 125
Non-coding RNAs: An emerging player in DNA damage response
Zhang, C., & Peng, G. (2014) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2014.11.003 · Cited by 124
Effect of melatonin on experimental tumors under different photoperiods and times of administration
Bartsch, H., & Bartsch, C. (1981) · Journal of Neural Transmission · doi:10.1007/bf01256752 · Cited by 123
Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1)
Leja‐Szpak, A., Jaworek, J. M., Pierzchalski, P., & Reiter, R. J. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00789.x · Cited by 117
Self-citationKim, K., Choi, J., Kang, I., Kim, K., Jeong, C., & Jeong, J. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.01030.x · Cited by 117
Melatonin and protection from whole-body irradiation: survival studies in mice
Vijayalaxmi, V., Meltz, M. L., Reiter, R. J., Herman, T. S., & Sree Kumar, K. (1999) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(98)00246-2 · Cited by 115
Self-citationQi, W., Reiter, R. J., Tan, D. X., Manchester, L. C., Siu, A. W., & García, J. J. (2000) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2000.290108.x · Cited by 113
Self-citationMatrix metalloproteinases in health and disease: regulation by melatonin
Swarnakar, S., Paul, S., Singh, L. P., & Reiter, R. J. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00812.x · Cited by 112
Self-citationCircadian rhythms and tumor growth
Greene, M. W. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.01.001 · Cited by 112
Sohn, E. J., Won, G., Lee, J., Lee, S., & Kim, S. (2014) · Journal of Cancer · doi:10.7150/jca.9591 · Cited by 112
Quinone reductase 2 as a promising target of melatonin therapeutic actions
Boutin, J. A. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1091882 · Cited by 111
Śliwiński, T., Rożej-Bielicka, W., Morawiec-Bajda, A., Morawiec, Z., Reiter, R. J., & Błasiak, J. (2007) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2007.07.013 · Cited by 111
Self-citationShort‐wavelength enrichment of polychromatic light enhances human melatonin suppression potency
Brainard, G. C., Hanifin, J. P., Warfield, B., Stone, M. K., James, M. E., Ayers, M. A., Kubey, A. A., Byrne, B. G., & Rollag, M. D. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12221 · Cited by 110
Phiboonchaiyanan, P. P., Weerapreeyakul, N., Barusrux, S., & Johns, N. (2015) · Cell Proliferation · doi:10.1111/cpr.12158 · Cited by 109
León, J., Casado, J., Ruiz, S. M. J., Zurita, M. S., González‐Puga, C., Rejón, J. D., Gila, A., de Rueda, P. M., Pavón, E. J., Reiter, R. J., et al. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12131 · Cited by 109
Self-citation
Cited by
Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas
Reiter, R. J., Rosales-Corral, S., Tan, D. X., Jou, M. J., Galano, A., & Xu, B. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2609-7 · Cited by 558
Self-citationMelatonin: A Cutaneous Perspective on its Production, Metabolism, and Functions
Slominski, A. T., Hardeland, R., Zmijewski, M. A., Slominski, R. M., Reiter, R. J., & Paus, R. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.10.025 · Cited by 286
Self-citationTargeting Notch in oncology: the path forward
Majumder, S., Crabtree, J. S., Golde, T. E., Minter, L. M., Osborne, B. A., & Miele, L. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00091-3 · Cited by 270
Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases
Chen, D., Zhang, T., & Lee, T. H. (2020) · Biomolecules · doi:10.3390/biom10081158 · Cited by 140
Involvement of NRF2 in Breast Cancer and Possible Therapeutical Role of Polyphenols and Melatonin
Tascioglu Aliyev, A., Panieri, E., Stepanić, V., Gurer-Orhan, H., & Saso, L. (2021) · Molecules · doi:10.3390/molecules26071853 · Cited by 50
Metadata
- Authors
- Reiter, R., Rosales-Corral, S., Tan, D.-X., Acuna-Castroviejo, D., Qin, L., Yang, S.-F., & Xu, K.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-04-17
- Volume
- 18
- Issue
- 4
- Pages
- 843
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2606778500
- Cited by
- 433
- References
- 341
- FWCI
- 22.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.